# Cell Therapy for Craniofacial Bone Defects

> **NCT01616953** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Michigan** · enrollment: 18 (actual)

## Conditions studied

- Cleft Palate
- Trauma

## Interventions

- **BIOLOGICAL:** Ixmyelocel-T
- **PROCEDURE:** Autogenous Bone Grafting

## Key facts

- **NCT ID:** NCT01616953
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2017-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01616953

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01616953, "Cell Therapy for Craniofacial Bone Defects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01616953. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*